{"id":{"repo_id":"brock","oai_identifier":"oai:brocku.scholaris.ca:10464/18266"},"canonical_url":"https://search.dev.ndltd.org/etd/brock/oai:brocku.scholaris.ca:10464/18266","repository":{"repo_id":"brock","name":"Brock University","base_url":"https://brocku.scholaris.ca/server/oai/request"},"display":{"title":"Combining the Power of Attention Models and Many-objective Computational Intelligence Algorithms for Drug Design","abstract":"AI-based approaches have been recently applied to in silico drug design. However, existing approaches and protocols consider the absorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic properties of drug candidates in a later stage of drug design processes, where failure is most costly. To address this challenge, this research work aims to achieve three objectives. First, it explores the use of Transformer-based models for ADMET prediction based on a hybrid fragment-SMILES tokenization scheme and two training strategies. Second, it evaluates the performance of contrastive Transformer-based latent models for molecular generation. Third, it applies many-objective computational intelligence algorithms in the continuous latent space generated by a Transformer model to generate optimal drug candidates that fulfill ADMET and other essential properties in parallel. The results of this research work demonstrate superiority in the hybrid approach over SMILES in predicting ADMET properties. Furthermore, the system proposed in this study integrates metaheuristics with ADMET prediction and latent Transformer models for solving a drug design problem. A comparative study shows effectiveness of computational intelligence towards a many-objective drug design problem, where 1718 drug-like molecules are obtained after application of a strict filtering criteria.","abstract_html":"AI-based approaches have been recently applied to in silico drug design. However, existing approaches and protocols consider the absorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic properties of drug candidates in a later stage of drug design processes, where failure is most costly. To address this challenge, this research work aims to achieve three objectives. First, it explores the use of Transformer-based models for ADMET prediction based on a hybrid fragment-SMILES tokenization scheme and two training strategies. Second, it evaluates the performance of contrastive Transformer-based latent models for molecular generation. Third, it applies many-objective computational intelligence algorithms in the continuous latent space generated by a Transformer model to generate optimal drug candidates that fulfill ADMET and other essential properties in parallel. The results of this research work demonstrate superiority in the hybrid approach over SMILES in predicting ADMET properties. Furthermore, the system proposed in this study integrates metaheuristics with ADMET prediction and latent Transformer models for solving a drug design problem. A comparative study shows effectiveness of computational intelligence towards a many-objective drug design problem, where 1718 drug-like molecules are obtained after application of a strict filtering criteria.","abstract_has_math":false,"creators":["Aksamit, Nicholas"],"institution":"Brock University","degree_name":"M.Sc. Computer Science","degree_level":"Masters","degree_discipline":"Faculty of Mathematics and Science","degree_department":"Department of Computer Science","school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-02-12T20:27:51Z","date_published":"2024-02-12T20:27:51Z","updated_at":"2026-07-24T01:23:05Z","subjects":["cancer drug design","Transformers","ADMET prediction","molecular generation","many-objective metaheuristics"],"languages":["eng"],"rights":["CC0 1.0 Universal"],"rights_urls":["http://creativecommons.org/publicdomain/zero/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10464/18266","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.department","label":"Department","values":["Department of Computer Science"]},{"key":"dc:creator","label":"Author","values":["Aksamit, Nicholas"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-02-12T20:27:51Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-02-12T20:27:51Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-02-12T20:27:51Z"]},{"key":"dc:type","label":"Dc Type","values":["Electronic Thesis or Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Faculty of Mathematics and Science"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.Sc. Computer Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Brock University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["cancer drug design","Transformers","ADMET prediction","molecular generation","many-objective metaheuristics"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["CC0 1.0 Universal"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/publicdomain/zero/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10464/18266"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["AI-based approaches have been recently applied to in silico drug design. However, existing approaches and protocols consider the absorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic properties of drug candidates in a later stage of drug design processes, where failure is most costly. To address this challenge, this research work aims to achieve three objectives. First, it explores the use of Transformer-based models for ADMET prediction based on a hybrid fragment-SMILES tokenization scheme and two training strategies. Second, it evaluates the performance of contrastive Transformer-based latent models for molecular generation. Third, it applies many-objective computational intelligence algorithms in the continuous latent space generated by a Transformer model to generate optimal drug candidates that fulfill ADMET and other essential properties in parallel. The results of this research work demonstrate superiority in the hybrid approach over SMILES in predicting ADMET properties. Furthermore, the system proposed in this study integrates metaheuristics with ADMET prediction and latent Transformer models for solving a drug design problem. A comparative study shows effectiveness of computational intelligence towards a many-objective drug design problem, where 1718 drug-like molecules are obtained after application of a strict filtering criteria."]},{"key":"dc:title","label":"Title","values":["Combining the Power of Attention Models and Many-objective Computational Intelligence Algorithms for Drug Design"]}]}],"canonical_facts":{"dc:contributor.department":["Department of Computer Science"],"dc:creator":["Aksamit, Nicholas"],"dc:date.accessioned":["2024-02-12T20:27:51Z"],"dc:date.available":["2024-02-12T20:27:51Z"],"dc:date.issued":["2024-02-12T20:27:51Z"],"dc:description.abstract":["AI-based approaches have been recently applied to in silico drug design. However, existing approaches and protocols consider the absorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic properties of drug candidates in a later stage of drug design processes, where failure is most costly. To address this challenge, this research work aims to achieve three objectives. First, it explores the use of Transformer-based models for ADMET prediction based on a hybrid fragment-SMILES tokenization scheme and two training strategies. Second, it evaluates the performance of contrastive Transformer-based latent models for molecular generation. Third, it applies many-objective computational intelligence algorithms in the continuous latent space generated by a Transformer model to generate optimal drug candidates that fulfill ADMET and other essential properties in parallel. The results of this research work demonstrate superiority in the hybrid approach over SMILES in predicting ADMET properties. Furthermore, the system proposed in this study integrates metaheuristics with ADMET prediction and latent Transformer models for solving a drug design problem. A comparative study shows effectiveness of computational intelligence towards a many-objective drug design problem, where 1718 drug-like molecules are obtained after application of a strict filtering criteria."],"dc:identifier.uri":["http://hdl.handle.net/10464/18266"],"dc:language.iso":["eng"],"dc:rights":["CC0 1.0 Universal"],"dc:rights.uri":["http://creativecommons.org/publicdomain/zero/1.0/"],"dc:subject":["cancer drug design","Transformers","ADMET prediction","molecular generation","many-objective metaheuristics"],"dc:title":["Combining the Power of Attention Models and Many-objective Computational Intelligence Algorithms for Drug Design"],"dc:type":["Electronic Thesis or Dissertation"],"thesis:degree_discipline":["Faculty of Mathematics and Science"],"thesis:degree_level":["Masters"],"thesis:degree_name":["M.Sc. Computer Science"],"thesis:institution_name":["Brock University"]},"updated_at":"2026-07-24T01:23:05Z"}